Literature DB >> 12730776

Men, bone and estrogen: unresolved issues.

E S Orwoll1.   

Abstract

Gonadal function has long been known to be important for skeletal health in men. Prepubertal hypogonadism is clearly associated with impairment in peak bone mass development and adult-onset hypogonadism with accelerated bone loss. Gonadal failure results in deficits in both androgen and estrogen action, but traditionally androgens were assumed to have the most important skeletal effect in men. Recently that model has been reconsidered as a variety of kinds of evidence have appeared to document a critical role for estrogen in bone physiology. As a result of this fresh perspective a host of interesting new dilemmas and hypotheses are being examined, including those related to the mechanisms of sex steroid action in bone, the origins of gender differences in skeletal morphology and physiology, and the role of estrogen in diagnostic and therapeutic strategies in men with metabolic bone disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12730776     DOI: 10.1007/s00198-002-1332-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  47 in total

1.  Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.

Authors:  S Khosla; L J Melton; E J Atkinson; W M O'Fallon
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

2.  Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells.

Authors:  J Arts; G G Kuiper; J M Janssen; J A Gustafsson; C W Löwik; H A Pols; J P van Leeuwen
Journal:  Endocrinology       Date:  1997-11       Impact factor: 4.736

3.  Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency.

Authors:  J P Bilezikian; A Morishima; J Bell; M M Grumbach
Journal:  N Engl J Med       Date:  1998-08-27       Impact factor: 91.245

Review 4.  Sex hormones and osteoporosis in men.

Authors:  F H Anderson; R M Francis; P L Selby; C Cooper
Journal:  Calcif Tissue Int       Date:  1998-03       Impact factor: 4.333

5.  Preliminary report of impaired oestrogen receptor-alpha expression in bone, but no involvement of androgen receptor, in male idiopathic osteoporosis.

Authors:  I P Braidman; C Baris; P L Selby; J E Adams; A J Freemont; J A Hoyland
Journal:  J Pathol       Date:  2000-09       Impact factor: 7.996

6.  Bone has a sexually dimorphic response to aromatase deficiency.

Authors:  O K Oz; J E Zerwekh; C Fisher; K Graves; L Nanu; R Millsaps; E R Simpson
Journal:  J Bone Miner Res       Date:  2000-03       Impact factor: 6.741

Review 7.  Clinical review 144: Estrogen and the male skeleton.

Authors:  Sundeep Khosla; L Joseph Melton; B Lawrence Riggs
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

8.  Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats.

Authors:  R T Turner; G K Wakley; K S Hannon
Journal:  J Orthop Res       Date:  1990-07       Impact factor: 3.494

9.  Estrogen receptor blockade with tamoxifen diminishes growth hormone secretion in boys: evidence for a stimulatory role of endogenous estrogens during male adolescence.

Authors:  D L Metzger; J R Kerrigan
Journal:  J Clin Endocrinol Metab       Date:  1994-08       Impact factor: 5.958

10.  Calcium and protein kinetics in prepubertal boys. Positive effects of testosterone.

Authors:  N Mauras; M W Haymond; D Darmaun; N E Vieira; S A Abrams; A L Yergey
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

View more
  9 in total

Review 1.  Chemistry and structural biology of androgen receptor.

Authors:  Wenqing Gao; Casey E Bohl; James T Dalton
Journal:  Chem Rev       Date:  2005-09       Impact factor: 60.622

2.  Dehydroepiandrosterone sulfate and bone resorption rates as reflected by serum levels of C-terminal telopeptide of type I collagen: a study in healthy men.

Authors:  V Carnevale; A Scillitani; E Vecci; E D'Erasmo; E Romagnoli; F Paglia; J Pepe; V Baldini; C Santori; S De Geronimo; S Minisola
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

Review 3.  Bone health and the female athlete triad in adolescent athletes.

Authors:  Kathryn E Ackerman; Madhusmita Misra
Journal:  Phys Sportsmed       Date:  2011-02       Impact factor: 2.241

Review 4.  Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs).

Authors:  Wenqing Gao; James T Dalton
Journal:  Drug Discov Today       Date:  2007-02-07       Impact factor: 7.851

5.  Changes in first hip fracture rates in British Columbia Canada, 1990-2004.

Authors:  K A Lefaivre; A R Levy; B Sobolev; S Y Cheng; L Kuramoto; P Guy
Journal:  Osteoporos Int       Date:  2011-01-11       Impact factor: 4.507

Review 6.  Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands.

Authors:  Wenqing Gao; Juhyun Kim; James T Dalton
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

7.  The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men.

Authors:  Erin S LeBlanc; Carrie M Nielson; Lynn M Marshall; Jodi A Lapidus; Elizabeth Barrett-Connor; Kristine E Ensrud; Andrew R Hoffman; Gail Laughlin; Claes Ohlsson; Eric S Orwoll
Journal:  J Clin Endocrinol Metab       Date:  2009-07-07       Impact factor: 5.958

8.  BMI and low bone mass in an elderly male nursing home population.

Authors:  Miguel A Paniagua; Julie E Malphurs; Luis F Samos
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

Review 9.  Male Osteoporosis in the Elderly.

Authors:  Patrizia D'Amelio; Giovanni Carlo Isaia
Journal:  Int J Endocrinol       Date:  2015-09-20       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.